Research Type: Extramural
This innovative research could be a breakthrough in treating pancreatic cancer and improving survival outcomes.
Prof Molloy wants to understand why and how polyps become cancerous to reduce the incidence of bowel cancer in Australia.
This project will improve understanding of what causes treatment resistance in ER+ breast cancer and identify new ways to overcome it.
A/Prof Pickett has developed a potential new drug that targets the process cancers use to grow and survive.
This project has worked to improve treatments and reduce the major challenge of some breast cancer patients’ resistance to endocrine therapy and relapse.
Dr Wang and her team have identified a new treatment target for one of the most lethal forms of leukaemia.
Dr Micklethwaite has been developing myeloma-specific CAR T-cells – immune cells specifically designed to recognise and destroy myeloma cells.
Prof Tangye is studying patients with immune deficiencies and how this leads to the development of lymphoma cancers.
Professor Croucher and his team have demonstrated the potential of a newly approved treatment for osteoporosis to strengthen and rebuild bone damaged by myeloma.
Professor Watkins and his team have shown that osteosarcomas rely on a specific molecular pathway to grow. The team is now researching ways to block this pathway to stop tumour growth.